Advertisement
PerkinElmer
PerkinElmer

The Nutshell

» cell & molecular biology, funding, ecology and cancer

Daily News Roundup

Most Recent

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: The Death Toll Tied to Sweet Drinks

The Death Toll Tied to Sweet Drinks

By | July 1, 2015

Annually, about 184,000 deaths annually are linked to drinking sugary beverages, according to a new study.

7 Comments

image: Ravenous Invasive Worm Now in U.S.

Ravenous Invasive Worm Now in U.S.

By | June 25, 2015

Researchers have found the New Guinea flatworm, one of the world’s most invasive species, in Florida, putting native ecosystems at serious risk.

0 Comments

image: Regenerative Cardiomyocytes Found

Regenerative Cardiomyocytes Found

By | June 24, 2015

Specialized cardiac cells in the mouse heart appear to be the long-sought-after proliferative heart cells.

0 Comments

image: Extra DNA Base Discovered

Extra DNA Base Discovered

By | June 23, 2015

An epigenetic variant of cytosine is stable in the genomes of living mice, suggesting a possible expansion of the DNA alphabet.

0 Comments

image: The Handedness of Cells

The Handedness of Cells

By | June 17, 2015

Actin—the bones of the cell—has a preference for swirling into a counterclockwise pattern.

0 Comments

image: The Cost of Irreproducible Research

The Cost of Irreproducible Research

By | June 10, 2015

Half of basic science studies cannot be replicated, according to a new analysis—to the tune of $28 billion a year in the U.S.

5 Comments

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Artificial bases that act like the real deal can be designed to bind specifically to tumor cells.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.

0 Comments

Advertisement

Popular Now

  1. Staying Active in the Lab
    Careers Staying Active in the Lab

    Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

  2. When Does a Smart Mouse Become Human?
  3. The Lies That Scars Tell
    Notebook The Lies That Scars Tell

    Macaque trainers in Bangladesh are often bitten by their monkeys, but rarely infected by a particular simian retrovirus.

  4. Antibiotic Resistance Can Boost Bacterial Fitness
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist